Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON39118
NL-OMON39118
Completed
Not Applicable

Biomarkers of cartilage and bone damage after joint bleeds in haemophiliacs - Biomarkers after joint bleeds in haemophiliacs

niversitair Medisch Centrum Utrecht0 sites10 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsclotting factor VIII/IX deficiency1001884910023213

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
clotting factor VIII/IX deficiency
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
10
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • •Haemophilia, joint bleed

Exclusion Criteria

  • •HIV positivity, overweight, antibodies against clotting factor

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Articular cartilage changes following meniscectomy
PACTR201403000801118Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, University of Alexandria.40
Completed
Not Applicable
Prognostic factors for cartilage degeneration in the knee after meniscectomy and cruciate ligament injuries. A prospective observational magnetic resonance imaging cohort study.OsteoarthritisMusculoskeletal Diseases
ISRCTN44431821Dutch Arthritis Association (The Netherlands)700
Completed
Not Applicable
Prognostic factors for cartilage degeneration in the knee after meniscectomy and cruciate ligament injuries. A prospective observational MRI cohort studyCartilage degenerationdegenerative disease1002321310005944
NL-OMON29928Reumafonds700
Completed
Not Applicable
Investigation of the effects of cartilage structure nutrients on symptoms of knee osteoarthritis: a 12-weeks, randomized, double-blind, placebo-controlled pilot studyM17Gonarthrosis [arthrosis of knee]
DRKS00029563Apomedica Pharmazeutische Produkte GmbH54
Completed
Not Applicable
Assessment of bone related bio-markers in patients with rheumatoid arthritis treated with Certolizumab pegolrheumatoid arthritis
JPRN-UMIN000029594Graduate School of Medicine, Osaka University Department of Respiratory Medicine and Clinical Immunology40